View this on-demand webinar to learn how to increase potential for long-term success and ensure donor pool sustainability in allogeneic and autologous programs. Discover the keys to enabling a smoother, faster transition to market and ultimately, access to more patients.
Our expert panelists will cover:
- What to expect when transitioning from small trial sizes to large volumes, while also managing the disruptions inevitably associated with delivering human-based therapies
- The importance of established global partnerships and strategies critical to successfully orchestrating scalable logistics in a highly variable environment
- How donor pool size impacts scalable sourcing of quality starting material and how to ensure donor pool sustainability
- How you can transform specialized and diverse knowledge of apheresis processes into highly productive site onboarding and training
Our panel includes:
- Chris Learn, PhD, Senior Director, Therapeutic Science & Strategy, IQVIA
- Ray Hornung, MBA, CEM, CBCP, Senior Manager, Logistics and Emergency Preparedness, NMDP BioTherapies (formerly Be The Match BioTherapies)
- Amit Agarwal, Managing Director, Life Sciences, Deloitte Consulting
View webinar
